Effect of tamoxifen on serum cholesterol and lipoproteins during chemohormonal therapy
- 31 December 1993
- journal article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 223 (1-2) , 43-52
- https://doi.org/10.1016/0009-8981(93)90061-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- TAMOXIFEN USE, OESTROGEN BINDING AND SERUM LIPIDS IN POSTMENOPAUSAL WOMEN WITH BREAST CANCERAnz Journal of Surgery, 1990
- Long-term adjuvant tamoxifen therapy for breast cancerBreast Cancer Research and Treatment, 1990
- Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study.Journal of Clinical Oncology, 1990
- Effects of Tamoxifen Treatment on Plasma Lipids and Lipoprotein Lipid CompositionJournal of Clinical Endocrinology & Metabolism, 1990
- Long-term adjuvant tamoxifen therapy for breast cancer: The prelude to preventionCancer Treatment Reviews, 1990
- A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancerBritish Journal of Cancer, 1989
- Adjuvant tamoxifen in primary breast cancer: Influence on plasma lipids and antithrombin III levelsBreast Cancer Research and Treatment, 1988
- Tamoxifen, serum lipoproteins and cardiovascular riskBritish Journal of Cancer, 1988
- Chemosuppression of Breast Cancer with Tamoxifen: Laboratory Evidence and Future Clinical InvestigationsCancer Investigation, 1988
- Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifenAtherosclerosis, 1984